Scribe logoScribeNotes & practice
Sign inStart free
  1. Notes
  2. ›Edexcel A-level Biology A (Salters-Nuffield)
  3. ›4 Biodiversity and Natural Resources
  4. ›4.13 Drug testing

Edexcel A-level Biology A (Salters-Nuffield) · Topic 4 · Biodiversity and Natural Resources

4.13 Drug testing

Describe the main stages of drug testing, and explain why double-blind trials and placebo controls are used.

  • 5 min read
  • 6 parts
  • 10 questions
  • Draft
Start a Quick 5 on this topic→Jump to the 10 questions
1/6New drugs pass through several stages of testing
  1. 1New drugs pass through several stages of testing
  2. 2Clinical trials test the drug in people in three phases
  3. 3Bias can distort the results of a trial
  4. 4A placebo control separates drug effects from expectation
  5. 5Double-blind trials hide the treatment from everyone involved
  6. 6A fair comparison of trial groups shows the drug’s effect
  7. Check your recall
  8. Practice: 10 questions
1

Part 1 of 6: New drugs pass through several stages of testing

A medicine can look promising in the laboratory and still be unsafe in people. For this reason, drugs are tested in stages. Each stage answers a different question about safety or effect.

The first stage is pre-clinical testing. It uses cultured cells, computer models and animals. These show harmful effects and likely benefits before any person receives the drug.

Two points matter at every stage: whether the drug is safe, and whether it works. Whether it works is its efficacy. A drug that fails on either point is stopped.

Key terms · tap one for its definition

pre-clinical testing

Pre-clinical testing is the laboratory and animal testing of a new drug before it is given to any human volunteer.

efficacy

Efficacy is the ability of a drug to produce its intended beneficial effect.

Part 1 done

2

Part 2 of 6: Clinical trials test the drug in people in three phases

Once a drug passes pre-clinical tests, it enters a clinical trial in people. Each phase starts only if the earlier phase shows the drug is safe enough. Doses begin low and rise gradually, so that harm is noticed early. Phase 2 and phase 3 use patients, because only they can show whether the drug helps.

The three phases of a clinical trial

PhaseParticipantsMain aim
1Small group, often healthy volunteersSafety, dose range, side effects
2Small group of patients with the conditionEarly evidence of efficacy; best dose
3Large groups of patientsCompare with existing treatment or placebo
Phase
1
Participants
Small group, often healthy volunteers
Main aim
Safety, dose range, side effects
Phase
2
Participants
Small group of patients with the condition
Main aim
Early evidence of efficacy; best dose
Phase
3
Participants
Large groups of patients
Main aim
Compare with existing treatment or placebo

If phase 3 shows that the benefits outweigh the risks, regulators may license the drug. Monitoring continues afterwards to find rare side effects.

Common mistake

Phase 1 does not mainly test whether the drug works. Its first aim is safety.

Key term

clinical trial

A clinical trial is a planned investigation in which a new treatment is tested on human participants.

Part 2 done

Quick check

One question on the part you just read

Easy

Identify the stage in which a new drug is first given to people.
Show answer and explanation

Answer: D · Worked explanation

Phase 1 is the first stage in which people receive the drug, usually to test safety. Pre-clinical testing is tempting, but it uses cells, models and animals. Phase 3 and later monitoring happen only after earlier phases have succeeded, because each phase builds on the safety results before it.
3

Part 3 of 6: Bias can distort the results of a trial

A trial is useful only if its result can be trusted. Patients who know they are taking a new drug may feel better because they expect to. Researchers who know may judge symptoms more favourably without meaning to.

Both are examples of bias. Trials reduce it by random allocation. Each volunteer is placed in the drug group or the control group by chance. The groups are then similar in age, health and other features.

Large groups also reduce the effect of chance. A result from a handful of patients could easily be a coincidence.

Key terms · tap one for its definition

bias

Bias is a systematic influence that pushes the results of an investigation away from the true value in one direction.

random allocation

Random allocation is the placing of each participant in a treatment group by chance, so that the groups are similar on average.

Part 3 done

4

Part 4 of 6: A placebo control separates drug effects from expectation

Random allocation needs a comparison group. The control group often receives a placebo. This is a dummy treatment that looks and tastes like the drug but has no active ingredient.

Patients given a placebo often improve, because they expect the treatment to help. This is the placebo effect. Only the extra improvement in the drug group can be credited to the drug.

When an effective treatment already exists, withholding it would be unethical. The control group then receives the existing treatment instead.

Exam tip

In discussion answers, say that the placebo group shows the effect of expectation. Then say the drug’s effect is the difference between the two groups.

Key terms · tap one for its definition

placebo

A placebo is a treatment that looks the same as the drug being tested but contains no active ingredient.

placebo effect

The placebo effect is an improvement in a patient’s condition caused by expecting treatment, not by an active ingredient.

Part 4 done

Quick check

One question on the part you just read

Easy

State what a placebo is.
Show answer and explanation

Answer: C · Worked explanation

A placebo looks and tastes like the drug but contains no active ingredient. A lower dose of the drug still contains the active ingredient. An existing effective treatment is sometimes used for the control group, but that is not a placebo.
5

Part 5 of 6: Double-blind trials hide the treatment from everyone involved

A placebo helps only if nobody knows who received it. In a double-blind trial, neither the patients nor the researchers assessing them know who takes the drug. A separate person or system holds the code.

The code is revealed only after all measurements are complete. This removes expectation in the patients and bias in the researchers’ judgements. In a single-blind trial, only the patients are unaware.

Common mistake

Double-blind does not mean two groups of patients. It means two sets of people, patients and researchers, are unaware of who gets what.

Key term

double-blind trial

A double-blind trial is a trial in which neither the participants nor the researchers assessing them know who receives which treatment.

Part 5 done

6

Part 6 of 6: A fair comparison of trial groups shows the drug’s effect

Suppose 120 patients receive a drug and 120 receive a placebo. Count how many in each group improve, then compare the percentages. Percentages let groups of different sizes be compared fairly.

Worked example

Comparing two trial groups

In a trial, 78 of 120 patients taking the drug improved. In the placebo group, 42 of 120 improved. Calculate the difference in the percentage improved.
  1. 1
    Word equation: percentage improved = number improved divided by group size, multiplied by 100.
  2. 2
    Drug group: 78120×100=65%\frac{78}{120}\times100=65\%12078​×100=65%.
  3. 3
    Placebo group: 42120×100=35%\frac{42}{120}\times100=35\%12042​×100=35%.
  4. 4
    Difference: 65%−35%=3065\%-35\%=3065%−35%=30 percentage points.

Answer: The drug group improved by 30 percentage points more than the placebo group.

Part of the 35% in the placebo group reflects the placebo effect. A difference matters only if the groups are large enough, so researchers test whether chance could explain it. Reports should also give the group sizes. A difference of 30 points in groups of 10 is far less convincing than in groups of 100.

Note read

Check your recall[16 marks]

6 written questions. Answer each one in your head or on paper, then open the mark scheme.

  1. 1.Describe[4 marks]

    Describe the main stages in testing a new drug.

    Show mark schemeHide mark scheme

    Model answer

    Pre-clinical testing uses cells, models and animals. Phase 1 gives the drug to a small group, often healthy volunteers, to test safety. Phase 2 tests efficacy and dose in a small group of patients. Phase 3 compares the drug with a placebo or existing treatment in a large group.

    • 1 mark for stating that pre-clinical testing uses cells, models or animals
    • 1 mark for stating that phase 1 tests safety in a small group, often healthy volunteers
    • 1 mark for stating that phase 2 tests efficacy or dose in patients
    • 1 mark for stating that phase 3 compares the drug in a large group of patients
  2. 2.Explain[3 marks]

    Explain why a trial is made double-blind.

    Show mark schemeHide mark scheme

    Model answer

    Neither patients nor researchers know who takes the drug. Patient expectation therefore cannot change how they feel or report. Researchers cannot judge results more favourably, so bias is reduced.

    • 1 mark for stating that neither patients nor researchers know who receives the drug
    • 1 mark for explaining that this removes the effect of patient expectation
    • 1 mark for explaining that this removes researcher bias in measurements
  3. 3.Discuss[3 marks]

    Discuss the importance of placebo controls in drug trials.

    Show mark schemeHide mark scheme

    Model answer

    A placebo group shows how much improvement is due to expectation. The drug’s effect is the extra improvement in the drug group. If an effective treatment already exists, a placebo alone may be unethical, so the control group receives the existing treatment.

    • 1 mark for stating that the placebo group shows the placebo effect or expectation
    • 1 mark for explaining that the drug’s effect is the extra improvement over the placebo group
    • 1 mark for recognising that withholding an existing effective treatment would be unethical
  4. 4.Calculate[3 marks]

    Calculate the difference in the percentage improved when 99 of 150 patients on a drug and 45 of 150 patients on a placebo improved.

    Show mark schemeHide mark scheme

    Model answer

    Drug: 99150×100=66%\frac{99}{150}\times100=66\%15099​×100=66%. Placebo: 45150×100=30%\frac{45}{150}\times100=30\%15045​×100=30%. Difference = 66%−30%=3666\%-30\%=3666%−30%=36 percentage points.

    • 1 mark for calculating 66% for the drug group
    • 1 mark for calculating 30% for the placebo group
    • 1 mark for subtracting to give 36 percentage points
  5. 5.Suggest[2 marks]

    Suggest why phase 3 trials use many more patients than phase 1 trials.

    Show mark schemeHide mark scheme

    Model answer

    A large group reduces the effect of chance. It also allows differences in efficacy and rare side effects to be detected reliably.

    • 1 mark for stating that large groups reduce the effect of chance
    • 1 mark for stating that differences or rarer side effects can be detected reliably
  6. 6.Define[1 mark]

    Define the term placebo effect.

    Show mark schemeHide mark scheme

    Model answer

    The placebo effect is an improvement in a patient’s condition caused by expecting treatment, not by an active ingredient.

    • 1 mark for stating that it is an improvement caused by expectation, not an active ingredient

Practice this topic

10 quick-fire multiple-choice questions, easy to hard. Tap an answer to see if you're right and the worked explanation. (The written questions with mark schemes are under “Check your recall” above.)

0 right0 of 10 answered

Includes the 2 quick checks in the note above.

3.

Easy·State[1 mark]

State the main aim of phase 1 of a clinical trial.
Show answer and explanation

Answer: B · Worked explanation

Phase 1 mainly checks that the drug is safe and finds a suitable dose range, often in healthy volunteers. Comparing large groups of patients belongs to phase 3, and animal testing belongs to pre-clinical testing, which comes first. Doses start low so that harm is noticed early.
4.

Medium·Identify[1 mark]

Identify what makes a trial double-blind.
Show answer and explanation

Answer: A · Worked explanation

In a double-blind trial, both patients and researchers are unaware of who receives the drug. If only the patients are unaware, the trial is single-blind, which still allows researchers’ bias. Having two drugs or two phases has no bearing on the term.
5.

Medium·Calculate[2 marks]

In a trial, 63 of 90 patients on a drug improved, and 36 of 90 on a placebo improved. Calculate the difference in the percentage improved.
Show answer and explanation

Answer: D · Worked explanation

Drug: 6390×100=70%\frac{63}{90}\times100=70\%9063​×100=70%. Placebo: 3690×100=40%\frac{36}{90}\times100=40\%9036​×100=40%. Difference = 30 percentage points. The value 27 is the difference in the number of patients, not percentages. The value 43 divides the difference by the drug percentage. Always find each percentage first, then subtract, and give the answer in percentage points.
6.

Medium·Explain[1 mark]

Which is the main reason for using random allocation in a trial?
Show answer and explanation

Answer: C · Worked explanation

Placing patients in groups by chance makes the groups similar in features such as age and health, which reduces bias. It cannot guarantee that a drug works. Patients are usually not told their treatment, and random allocation still needs a control group to compare with.
7.

Medium·Explain[1 mark]

A serious infection already has an effective treatment. Why is the control group in a new drug trial usually given that treatment instead of a placebo alone?
Show answer and explanation

Answer: B · Worked explanation

Giving only a placebo to patients who have a proven treatment available would risk harm, so the control group receives the existing treatment. Placebos can look the same as drugs, and the placebo effect does not depend on being healthy.
8.

Hard·Analyse[2 marks]

In a trial, 70% of patients on a new drug improved and 55% of patients on a placebo improved. Which conclusion is best supported?
Show answer and explanation

Answer: A · Worked explanation

The placebo group shows how much improvement comes from expectation, so the drug’s extra effect is 70% minus 55%, which is 15 percentage points, provided chance is excluded. Crediting all 70% to the drug ignores the placebo effect. A placebo improvement does not make the drug ineffective.
9.

Hard·Analyse[2 marks]

In a trial, only the patients are unaware of which treatment they receive. The researcher who scores symptoms knows who took the drug. Which problem remains?
Show answer and explanation

Answer: D · Worked explanation

Because the researcher knows who took the drug, they may score symptoms more favourably without meaning to, which is bias. Patient expectation is already controlled, since patients are unaware. The blinding does not stop random allocation, and the placebo effect can still occur in patients.
10.

Hard·Explain[2 marks]

A drug is given to patients, and their symptoms are compared with their own symptoms before treatment. There is no control group. Why can this not show that the drug works?
Show answer and explanation

Answer: C · Worked explanation

Without a control group, there is nothing to separate the drug’s effect from the placebo effect, because patients may improve by expecting treatment to help. Measuring patients before treatment is normal practice, and patients with the condition are the right group in phase 2.

Keep going

Next topic4.14 Bacterial growth and plant antimicrobialsPrevious topic4.12 Water and inorganic ions in plants

More in Topic 4 · Biodiversity and Natural Resources

  1. 4.8Plant organelles in electron micrographsNotes · 10 questions
  2. 4.9Starch and celluloseNotes · 10 questions
  3. 4.10Cellulose microfibrils and plant cell wallsNotes · 10 questions
  4. 4.11Sclerenchyma, xylem and phloemNotes · 10 questions
  5. 4.12Water and inorganic ions in plantsNotes · 10 questions
  6. 4.13Drug testingNotes · 10 questions
  7. 4.14Bacterial growth and plant antimicrobialsNotes · 10 questions
  8. 4.15Plant fibres and sustainabilityNotes · 10 questions
  9. 4.16Zoos and seed banksNotes · 10 questions

All Edexcel A-level Biology A (Salters-Nuffield) topics →

Draft: written by Scribe and checked automatically, not yet by a subject reviewer.

Practice questions are original, written by Scribe and checked automatically for correctness.

Topic codes follow the official numbering. Not endorsed by Pearson Edexcel or any exam board.

On this page

0/6 read

  1. 1New drugs pass through several stages of testing
  2. 2Clinical trials test the drug in people in three phases
  3. 3Bias can distort the results of a trial
  4. 4A placebo control separates drug effects from expectation
  5. 5Double-blind trials hide the treatment from everyone involved
  6. 6A fair comparison of trial groups shows the drug’s effect
  7. Check your recall
  8. Practice: 10 questions
All coursesScribeHow it worksPricingPrivacyTerms

Notes and questions are written by Scribe in our own words. Topic codes follow the official course numbering so you can find your place. Not produced or endorsed by the IB, College Board, AQA, OCR, Pearson Edexcel or any exam board.

© 2026 Scribe